HOT-17
HOT-17 is a psychedelic drug and a member of the phenethylamine family. It is related to the more well-known compounds 2C-E and DOB. HOT-17 was first synthesized and studied by the team led by Alexander Shulgin.
Chemistry[edit | edit source]
HOT-17, or 2,5-dimethoxy-4-(β-isohexyl)-phenethylamine, is a substituted phenethylamine featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain. HOT-17 shares this phenethylamine structure with other psychedelic drugs like mescaline and 2C-B.
Pharmacology[edit | edit source]
The pharmacological mechanisms of HOT-17 are not well understood. It is believed to act as a 5-HT2A receptor agonist, similar to other psychedelic phenethylamines. However, the exact nature of its interactions with the 5-HT2A receptor and other potential targets is not known.
Effects[edit | edit source]
The effects of HOT-17 are largely unknown due to the lack of scientific research. Anecdotal reports suggest that it produces effects similar to other psychedelic phenethylamines, including open and closed-eye visuals, time distortion, enhanced introspection, and altered auditory and visual perception.
Legality[edit | edit source]
The legality of HOT-17 varies by country. In the United States, it is not specifically listed as a controlled substance, but it could potentially be considered an analog of DOB, which is a Schedule I drug under the Controlled Substances Act.
See also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD